Diane M. Simeone
Affiliations: | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Cell BiologyGoogle:
"Diane Simeone"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Werba G, Weissinger D, Kawaler EA, et al. (2023) Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment. Nature Communications. 14: 797 |
| Pan S, Lai LA, Simeone DM, et al. (2022) Proteomes of Extracellular Vesicles From Pancreatic Cancer Cells and Cancer-Associated Fibroblasts. Pancreas. 51: 790-799 |
| Xu J, Yang R, Li J, et al. (2022) DNMT3A//Rac1 Is an Effector Pathway for to Drive Stem-Cell-like and Invasive Behaviors of Advanced Bladder Cancer Cells. Cancers. 14 |
| Gonda TA, Farrell J, Wallace M, et al. (2021) Standardization of EUS imaging and reporting in high-risk individuals of pancreatic adenocarcinoma: consensus statement of the Pancreatic Cancer Early Detection Consortium (PRECEDE). Gastrointestinal Endoscopy |
| Gonda TA, Everett JN, Wallace M, et al. (2021) Recommendations for a More Organized and Effective Approach to the Early Detection of Pancreatic Cancer From the PRECEDE (Pancreatic Cancer Early Detection) Consortium. Gastroenterology. 161: 1751-1757 |
| Purohit V, Wang L, Yang H, et al. (2021) ATDC binds to KEAP1 to drive NRF2-mediated tumorigenesis and chemoresistance in pancreatic cancer. Genes & Development |
| Grant RC, Denroche R, Jang GH, et al. (2020) Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma. Gut |
| Gout J, Perkhofer L, Morawe M, et al. (2020) Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer. Gut |
| Grossberg AJ, Chu LC, Deig CR, et al. (2020) Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma. Ca: a Cancer Journal For Clinicians |
| Brunton H, Caligiuri G, Cunningham R, et al. (2020) HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer. Cell Reports. 31: 107625 |